TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0

作者：

Peirs, S. ^{[1
]}

Frismantas, V. ^{[2
]}

Matthijssens, F. ^{[1
]}

Lintermans, B. ^{[1
]}

Pieters, T. ^{[1
,3
,4
]}

Vandamme, N. ^{[3
,4
]}

Van Loocke, W. ^{[1
]}

Berx, G. ^{[3
,4
]}

Poppe, B. ^{[1
]}

Bourquin, J. P. ^{[2
]}

Van Vlierberghe, P. ^{[1
]}

机构：

[1] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium

[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Pediat Oncol, Zurich, Switzerland

[3] Univ Ghent, Unit Mol & Cellular Oncol, VIB Inflammat Res Ctr, Ghent, Belgium

[4] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P536

引用

页码：201 / 202

页数：2

共 50 条

[31] Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia
Laukkanen, Saara
Veloso, Alexandra
Yan, Chuan
Oksa, Laura
Alpert, Eric J.
Do, Daniel
Hyvarinen, Noora
McCarthy, Karin
Adhikari, Abhinav
Yang, Qiqi
Iyer, Sowmya
Garcia, Sara P.
Pello, Annukka
Ruokoranta, Tanja
Moisio, Sanni
Adhikari, Sadiksha
Yoder, Jeffrey A.
Gallagher, Kayleigh
Whelton, Lauren
Allen, James R.
Jin, Alex H.
Loontiens, Siebe
Heinaniemi, Merja
Kelliher, Michelle
Heckman, Caroline A.
Lohi, Olli
Langenau, David M.
BLOOD, 2022, 140 (17) : 1891 - 1906
[32] MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia
Summers, Ryan J.
Minson, Katherine A.
Wang, Xiaodong
Frye, Stephen V.
Earp, H. Shelton
DeRyckere, Deborah
Graham, Douglas K.
CANCER RESEARCH, 2018, 78 (19)
[33] MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia
Summers, Ryan J.
Minson, Katherine A.
Vasileiadi, Eleana
Wang, Xiaodong
Frye, Steven V.
Earp, H. Shelton
DeRyckere, Deborah
Graham, Douglas K.
CANCER RESEARCH, 2019, 79 (13)
[34] Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Bride, Karen L.
Vincent, Tiffaney L.
Im, Soo-Yeon
Aplenc, Richard
Barrett, David M.
Carroll, William L.
Carson, Robin
Dai, Yunfeng
Devidas, Meenakshi
Dunsmore, Kimberly P.
Fuller, Tori
Glisovic-Aplenc, Tina
Horton, Terzah M.
Hunger, Stephen P.
Loh, Mignon L.
Maude, Shannon L.
Raetz, Elizabeth A.
Winter, Stuart S.
Grupp, Stephan A.
Hermiston, Michelle L.
Wood, Brent L.
Teachey, David T.
BLOOD, 2018, 131 (09) : 995 - 999
[35] Preclinical Efficacy of Daratumumab in T-Cell Acute Lymphoblastic Leukemia
Bride, K. L.
Vincent, T.
Im, L.
Ryan, T.
Fuller, T.
Barrett, D. M.
Maude, S. L.
Hermiston, M. L.
Grupp, S. A.
Wood, B. L.
Teachey, D. T.
PEDIATRIC BLOOD & CANCER, 2017, 64 : S69 - S70
[36] ζ-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia
Lapucci, Andrea
Lulli, Matteo
Amedei, Amedeo
Papucci, Laura
Witort, Ewa
Di Gesualdo, Federico
Bertolini, Francesco
Brewer, Gary
Nicolin, Angelo
Bevilacqua, Annamaria
Schiavone, Nicola
Morello, Dominique
Donnini, Martino
Capaccioli, Sergio
FASEB JOURNAL, 2010, 24 (06): : 1852 - 1865
[37] Progress in targeting the BCL-2 family of proteins
Garner, Thomas P.
Lopez, Andrea
Reyna, Denis E.
Spitz, Adam Z.
Gavathiotis, Evripidis
CURRENT OPINION IN CHEMICAL BIOLOGY, 2017, 39 : 133 - 142
[38] Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises
Sarmento, Leonor M.
Barata, Joao T.
EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1403 - 1415
[39] BCL-2, a Therapeutic Target for High Risk Hypodiploid B-Cell Acute Lymphoblastic Leukemia
Diaz-Flores, Ernesto
Comeaux, Evan Q.
Kim, Kailyn
Beckman, Kyle
Davis, Kara L.
Wu, Kevin
Akutagawa, Jon
Holmfeldt, Linda
Braun, Benjamin S.
Mullighan, Charles
Loh, Mignon L.
BLOOD, 2016, 128 (22)
[40] Bcl-2 family proteins and leukemia - Minireview
Kusenda, J
NEOPLASMA, 1998, 45 (03) : 117 - 122

← 1 2 3 4 5 →